ID   SUIS_HUMAN              Reviewed;        1827 AA.
AC   P14410; A2RUC3; Q1JQ80; Q1RMC2;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 6.
DT   10-MAY-2017, entry version 180.
DE   RecName: Full=Sucrase-isomaltase, intestinal;
DE   Contains:
DE     RecName: Full=Sucrase;
DE              EC=3.2.1.48;
DE   Contains:
DE     RecName: Full=Isomaltase;
DE              EC=3.2.1.10;
GN   Name=SI;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS ALA-231 AND ILE-1523.
RC   TISSUE=Intestine;
RX   PubMed=1353958; DOI=10.1042/bj2850915;
RA   Chantret I., Lacasa M., Chevalier G., Ruf J., Islam I., Mantei N.,
RA   Edwards Y., Swallow D., Rousset M.;
RT   "Sequence of the complete cDNA and the 5' structure of the human
RT   sucrase-isomaltase gene. Possible homology with a yeast
RT   glucoamylase.";
RL   Biochem. J. 285:915-923(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS PHE-15; ALA-231
RP   AND ILE-1523.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-679, AND VARIANT ALA-231.
RX   PubMed=2962903; DOI=10.1016/0378-1119(87)90181-8;
RA   Green F., Edwards Y., Hauri H.-P., Povey S., Ho M.W., Pinto M.,
RA   Swallow D.;
RT   "Isolation of a cDNA probe for a human jejunal brush-border hydrolase,
RT   sucrase-isomaltase, and assignment of the gene locus to chromosome
RT   3.";
RL   Gene 57:101-110(1987).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-20 AND 1008-1024, TISSUE SPECIFICITY, AND
RP   VARIANT PHE-15.
RX   PubMed=1677636;
RA   Gorvel J.P., Ferrero A., Chambraud L., Rigal A., Bonicel J.,
RA   Maroux S.;
RT   "Expression of sucrase-isomaltase and dipeptidylpeptidase IV in human
RT   small intestine and colon.";
RL   Gastroenterology 101:618-625(1991).
RN   [6]
RP   PHOSPHORYLATION AT SER-7.
RX   PubMed=8521865; DOI=10.1111/j.1432-1033.1995.963_3.x;
RA   Keller P., Semenza G., Shaltiel S.;
RT   "Phosphorylation of the N-terminal intracellular tail of sucrase-
RT   isomaltase by cAMP-dependent protein kinase.";
RL   Eur. J. Biochem. 233:963-968(1995).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 62-931 ALONE AND IN COMPLEX
RP   WITH INHIBITOR, GLYCOSYLATION AT ASN-99; ASN-455; ASN-855 AND ASN-904,
RP   FUNCTION, ACTIVE SITE, SUBSTRATE-BINDING SITES, AND DISULFIDE BONDS.
RX   PubMed=20356844; DOI=10.1074/jbc.M109.078980;
RA   Sim L., Willemsma C., Mohan S., Naim H.Y., Pinto B.M., Rose D.R.;
RT   "Structural basis for substrate selectivity in human maltase-
RT   glucoamylase and sucrase-isomaltase N-terminal domains.";
RL   J. Biol. Chem. 285:17763-17770(2010).
RN   [8]
RP   VARIANT CSID PRO-1098.
RX   PubMed=8609217; DOI=10.1172/JCI118459;
RA   Ouwendijk J., Moolenaar C.E.C., Peters W.J., Hollenberg C.P.,
RA   Ginsel L.A., Fransen J.A.M., Naim H.Y.;
RT   "Congenital sucrase-isomaltase deficiency: identification of a
RT   glutamine to proline substitution that leads to a transport block of
RT   sucrase-isomaltase in a pre-Golgi compartment.";
RL   J. Clin. Invest. 97:633-641(1996).
RN   [9]
RP   VARIANT CSID PRO-341, AND CHARACTERIZATION OF VARIANT CSID PRO-341.
RX   PubMed=10903344; DOI=10.1172/JCI9677;
RA   Jacob R., Zimmer K.P., Schmitz J., Naim H.Y.;
RT   "Congenital sucrase-isomaltase deficiency arising from cleavage and
RT   secretion of a mutant form of the enzyme.";
RL   J. Clin. Invest. 106:281-287(2000).
RN   [10]
RP   VARIANT CSID ARG-117, AND CHARACTERIZATION OF VARIANT CSID ARG-117.
RX   PubMed=11340066; DOI=10.1074/jbc.C100219200;
RA   Spodsberg N., Jacob R., Alfalah M., Zimmer K.P., Naim H.Y.;
RT   "Molecular basis of aberrant apical protein transport in an intestinal
RT   enzyme disorder.";
RL   J. Biol. Chem. 276:23506-23510(2001).
RN   [11]
RP   VARIANTS PHE-15 AND ALA-231, AND VARIANT CSID PRO-620.
RX   PubMed=14724820; DOI=10.1053/j.gastro.2003.09.022;
RA   Ritz V., Alfalah M., Zimmer K.P., Schmitz J., Jacob R., Naim H.Y.;
RT   "Congenital sucrase-isomaltase deficiency because of an accumulation
RT   of the mutant enzyme in the endoplasmic reticulum.";
RL   Gastroenterology 125:1678-1685(2003).
RN   [12]
RP   VARIANTS CSID GLY-577; PRO-594; PRO-694; ASP-1073; TYR-1229; GLY-1367
RP   AND CYS-1745, AND VARIANTS PHE-15; ALA-231 AND ILE-1523.
RX   PubMed=16329100; DOI=10.1002/humu.9392;
RA   Sander P., Alfalah M., Keiser M., Korponay-Szabo I., Kovacs J.B.,
RA   Leeb T., Naim H.Y.;
RT   "Novel mutations in the human sucrase-isomaltase gene (SI) that cause
RT   congenital carbohydrate malabsorption.";
RL   Hum. Mutat. 27:119-119(2006).
CC   -!- FUNCTION: Plays an important role in the final stage of
CC       carbohydrate digestion. Isomaltase activity is specific for both
CC       alpha-1,4- and alpha-1,6-oligosaccharides.
CC       {ECO:0000269|PubMed:20356844}.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of sucrose and maltose by an alpha-
CC       D-glucosidase-type action.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of (1->6)-alpha-D-glucosidic
CC       linkages in some oligosaccharides produced from starch and
CC       glycogen by alpha-amylase, and in isomaltose.
CC   -!- SUBUNIT: The resulting sucrase and isomaltase subunits stay
CC       associated with one another in a complex by non-covalent linkages.
CC       {ECO:0000269|PubMed:20356844}.
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane; Single-pass type II
CC       membrane protein. Note=Brush border.
CC   -!- TISSUE SPECIFICITY: Expressed in the poorly differentiated crypt
CC       cells of the small intestine as well as in the mature villous
CC       cells. Expressed at very low levels in the colon.
CC       {ECO:0000269|PubMed:1677636}.
CC   -!- PTM: The precursor is proteolytically cleaved when exposed to
CC       pancreatic proteases in the intestinal lumen.
CC   -!- PTM: Sulfated. {ECO:0000250}.
CC   -!- DISEASE: Congenital sucrase-isomaltase deficiency (CSID)
CC       [MIM:222900]: Autosomal recessive intestinal disorder that is
CC       clinically characterized by fermentative diarrhea, abdominal pain,
CC       and cramps upon ingestion of sugar. The symptoms are the
CC       consequence of absent or drastically reduced enzymatic activities
CC       of sucrase and isomaltase. The prevalence of CSID is 0.02 % in
CC       individuals of European descent and appears to be much higher in
CC       Greenland, Alaskan, and Canadian native people. CSID arises due to
CC       post-translational perturbations in the intracellular transport,
CC       polarized sorting, aberrant processing, and defective function of
CC       SI. {ECO:0000269|PubMed:10903344, ECO:0000269|PubMed:11340066,
CC       ECO:0000269|PubMed:14724820, ECO:0000269|PubMed:16329100,
CC       ECO:0000269|PubMed:8609217}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: There is a high degree of homology between the
CC       isomaltase and sucrase portions (41% of amino acid identity)
CC       indicating that this protein is evolved by partial gene
CC       duplication.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 31 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X63597; CAA45140.1; -; mRNA.
DR   EMBL; AC092695; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC140119; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC144561; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC115034; AAI15035.1; -; mRNA.
DR   EMBL; BC116452; AAI16453.1; -; mRNA.
DR   EMBL; BC132834; AAI32835.1; -; mRNA.
DR   EMBL; BC132860; AAI32861.1; -; mRNA.
DR   EMBL; M22616; AAA60551.1; -; mRNA.
DR   CCDS; CCDS3196.1; -.
DR   PIR; S36082; UUHU.
DR   RefSeq; NP_001032.2; NM_001041.3.
DR   UniGene; Hs.429596; -.
DR   PDB; 3LPO; X-ray; 3.20 A; A/B/C/D=62-931.
DR   PDB; 3LPP; X-ray; 2.15 A; A/B/C/D=62-931.
DR   PDBsum; 3LPO; -.
DR   PDBsum; 3LPP; -.
DR   ProteinModelPortal; P14410; -.
DR   SMR; P14410; -.
DR   MINT; MINT-4998644; -.
DR   STRING; 9606.ENSP00000264382; -.
DR   BindingDB; P14410; -.
DR   ChEMBL; CHEMBL2748; -.
DR   DrugBank; DB00284; Acarbose.
DR   DrugBank; DB00747; Scopolamine.
DR   CAZy; GH31; Glycoside Hydrolase Family 31.
DR   iPTMnet; P14410; -.
DR   PhosphoSitePlus; P14410; -.
DR   BioMuta; SI; -.
DR   DMDM; 317373594; -.
DR   MaxQB; P14410; -.
DR   PaxDb; P14410; -.
DR   PeptideAtlas; P14410; -.
DR   PRIDE; P14410; -.
DR   Ensembl; ENST00000264382; ENSP00000264382; ENSG00000090402.
DR   GeneID; 6476; -.
DR   KEGG; hsa:6476; -.
DR   UCSC; uc003fei.3; human.
DR   CTD; 6476; -.
DR   DisGeNET; 6476; -.
DR   GeneCards; SI; -.
DR   H-InvDB; HIX0030867; -.
DR   HGNC; HGNC:10856; SI.
DR   HPA; HPA011897; -.
DR   MalaCards; SI; -.
DR   MIM; 222900; phenotype.
DR   MIM; 609845; gene.
DR   neXtProt; NX_P14410; -.
DR   OpenTargets; ENSG00000090402; -.
DR   Orphanet; 306446; Congenital sucrase-isomaltase deficiency with minimal starch tolerance.
DR   Orphanet; 306474; Congenital sucrase-isomaltase deficiency with starch and lactose intolerance.
DR   Orphanet; 306436; Congenital sucrase-isomaltase deficiency with starch intolerance.
DR   Orphanet; 306462; Congenital sucrase-isomaltase deficiency without starch intolerance.
DR   Orphanet; 306486; Congenital sucrase-isomaltase deficiency without sucrose intolerance.
DR   PharmGKB; PA35758; -.
DR   eggNOG; KOG1065; Eukaryota.
DR   eggNOG; COG1501; LUCA.
DR   GeneTree; ENSGT00760000119229; -.
DR   HOGENOM; HOG000067936; -.
DR   HOVERGEN; HBG080721; -.
DR   InParanoid; P14410; -.
DR   KO; K01203; -.
DR   OMA; DQLPGDN; -.
DR   OrthoDB; EOG091G01E3; -.
DR   PhylomeDB; P14410; -.
DR   TreeFam; TF314577; -.
DR   BioCyc; MetaCyc:HS01688-MONOMER; -.
DR   BRENDA; 3.2.1.10; 2681.
DR   BRENDA; 3.2.1.48; 2681.
DR   Reactome; R-HSA-189085; Digestion of dietary carbohydrate.
DR   ChiTaRS; SI; human.
DR   EvolutionaryTrace; P14410; -.
DR   GenomeRNAi; 6476; -.
DR   PRO; PR:P14410; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000090402; -.
DR   CleanEx; HS_SI; -.
DR   ExpressionAtlas; P14410; baseline and differential.
DR   Genevisible; P14410; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005903; C:brush border; TAS:ProtInc.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; TAS:ProtInc.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0004558; F:alpha-1,4-glucosidase activity; EXP:Reactome.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:InterPro.
DR   GO; GO:0004574; F:oligo-1,6-glucosidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004575; F:sucrose alpha-glucosidase activity; TAS:Reactome.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro.
DR   GO; GO:0044245; P:polysaccharide digestion; TAS:Reactome.
DR   CDD; cd00111; Trefoil; 2.
DR   InterPro; IPR031727; Gal_mutarotase_N.
DR   InterPro; IPR011013; Gal_mutarotase_SF_dom.
DR   InterPro; IPR000322; Glyco_hydro_31.
DR   InterPro; IPR030458; Glyco_hydro_31_AS.
DR   InterPro; IPR030459; Glyco_hydro_31_CS.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   InterPro; IPR017957; P_trefoil_CS.
DR   InterPro; IPR000519; P_trefoil_dom.
DR   Pfam; PF01055; Glyco_hydro_31; 2.
DR   Pfam; PF16863; NtCtMGAM_N; 2.
DR   Pfam; PF00088; Trefoil; 2.
DR   SMART; SM00018; PD; 2.
DR   SUPFAM; SSF51445; SSF51445; 4.
DR   SUPFAM; SSF74650; SSF74650; 2.
DR   PROSITE; PS00129; GLYCOSYL_HYDROL_F31_1; 2.
DR   PROSITE; PS00707; GLYCOSYL_HYDROL_F31_2; 2.
DR   PROSITE; PS00025; P_TREFOIL_1; 1.
DR   PROSITE; PS51448; P_TREFOIL_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Glycoprotein; Glycosidase; Hydrolase; Membrane;
KW   Multifunctional enzyme; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Signal-anchor; Sulfation; Transmembrane;
KW   Transmembrane helix.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:1677636}.
FT   CHAIN         2   1827       Sucrase-isomaltase, intestinal.
FT                                /FTId=PRO_0000018551.
FT   CHAIN         2   1007       Isomaltase.
FT                                /FTId=PRO_0000018552.
FT   CHAIN      1008   1827       Sucrase.
FT                                /FTId=PRO_0000018553.
FT   TOPO_DOM      2     12       Cytoplasmic.
FT   TRANSMEM     13     32       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     33   1827       Lumenal.
FT   DOMAIN       61    110       P-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00779}.
FT   DOMAIN      932    978       P-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00779}.
FT   REGION      110   1007       Isomaltase.
FT   REGION     1008   1827       Sucrase.
FT   COMPBIAS     43     60       Ser/Thr-rich.
FT   ACT_SITE    505    505       Nucleophile; for isomaltase activity.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10066,
FT                                ECO:0000269|PubMed:20356844}.
FT   ACT_SITE    604    604       For isomaltase activity.
FT                                {ECO:0000269|PubMed:20356844}.
FT   ACT_SITE   1394   1394       Nucleophile; for sucrase activity.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10066,
FT                                ECO:0000269|PubMed:20356844}.
FT   ACT_SITE   1397   1397       For sucrase activity. {ECO:0000250}.
FT   ACT_SITE   1500   1500       Proton donor; for isomaltase activity.
FT                                {ECO:0000250}.
FT   BINDING     264    264       Substrate.
FT   BINDING     388    388       Substrate.
FT   BINDING     588    588       Substrate.
FT   BINDING     662    662       Substrate.
FT   MOD_RES       7      7       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:8521865}.
FT   MOD_RES     237    237       Sulfotyrosine. {ECO:0000255}.
FT   MOD_RES     239    239       Sulfotyrosine. {ECO:0000255}.
FT   MOD_RES     391    391       Sulfotyrosine. {ECO:0000255}.
FT   MOD_RES     400    400       Sulfotyrosine. {ECO:0000255}.
FT   MOD_RES     667    667       Sulfotyrosine. {ECO:0000255}.
FT   MOD_RES     763    763       Sulfotyrosine. {ECO:0000255}.
FT   MOD_RES     765    765       Sulfotyrosine. {ECO:0000255}.
FT   CARBOHYD     99     99       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:20356844}.
FT   CARBOHYD    437    437       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    455    455       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:20356844}.
FT   CARBOHYD    823    823       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    855    855       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:20356844}.
FT   CARBOHYD    904    904       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:20356844}.
FT   CARBOHYD    926    926       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1235   1235       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1303   1303       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1340   1340       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1354   1354       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1403   1403       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1535   1535       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1572   1572       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1675   1675       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1748   1748       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1763   1763       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1815   1815       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     63     94       {ECO:0000255|PROSITE-ProRule:PRU00779,
FT                                ECO:0000269|PubMed:20356844}.
FT   DISULFID     77     93       {ECO:0000255|PROSITE-ProRule:PRU00779,
FT                                ECO:0000269|PubMed:20356844}.
FT   DISULFID     88    106       {ECO:0000255|PROSITE-ProRule:PRU00779,
FT                                ECO:0000269|PubMed:20356844}.
FT   DISULFID    520    545       {ECO:0000255|PROSITE-ProRule:PRU00779,
FT                                ECO:0000269|PubMed:20356844}.
FT   DISULFID    635    646       {ECO:0000255|PROSITE-ProRule:PRU00779,
FT                                ECO:0000269|PubMed:20356844}.
FT   VARIANT      15     15       V -> F (in dbSNP:rs9290264).
FT                                {ECO:0000269|PubMed:14724820,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:16329100,
FT                                ECO:0000269|PubMed:1677636}.
FT                                /FTId=VAR_025367.
FT   VARIANT     117    117       Q -> R (in CSID; missorting of the enzyme
FT                                to the basolateral membrane;
FT                                dbSNP:rs121912612).
FT                                {ECO:0000269|PubMed:11340066}.
FT                                /FTId=VAR_025368.
FT   VARIANT     231    231       T -> A (in dbSNP:rs9283633).
FT                                {ECO:0000269|PubMed:1353958,
FT                                ECO:0000269|PubMed:14724820,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:16329100,
FT                                ECO:0000269|PubMed:2962903}.
FT                                /FTId=VAR_025369.
FT   VARIANT     341    341       L -> P (in CSID; causes loss of anchored
FT                                SI from the membrane; dbSNP:rs267607049).
FT                                {ECO:0000269|PubMed:10903344}.
FT                                /FTId=VAR_025370.
FT   VARIANT     577    577       V -> G (in CSID; dbSNP:rs121912615).
FT                                {ECO:0000269|PubMed:16329100}.
FT                                /FTId=VAR_025371.
FT   VARIANT     594    594       S -> P (in CSID; dbSNP:rs765433197).
FT                                {ECO:0000269|PubMed:16329100}.
FT                                /FTId=VAR_025372.
FT   VARIANT     620    620       L -> P (in CSID; SI accumulates
FT                                predominantly in the ER;
FT                                dbSNP:rs121912613).
FT                                {ECO:0000269|PubMed:14724820}.
FT                                /FTId=VAR_025373.
FT   VARIANT     694    694       T -> P (in CSID).
FT                                {ECO:0000269|PubMed:16329100}.
FT                                /FTId=VAR_025374.
FT   VARIANT    1073   1073       G -> D (in CSID; dbSNP:rs121912616).
FT                                {ECO:0000269|PubMed:16329100}.
FT                                /FTId=VAR_025375.
FT   VARIANT    1098   1098       Q -> P (in CSID; exhibits intracellular
FT                                accumulation of mannose-rich SI in the
FT                                Golgi; dbSNP:rs121912611).
FT                                {ECO:0000269|PubMed:8609217}.
FT                                /FTId=VAR_007854.
FT   VARIANT    1229   1229       C -> Y (in CSID; dbSNP:rs121912614).
FT                                {ECO:0000269|PubMed:16329100}.
FT                                /FTId=VAR_025376.
FT   VARIANT    1367   1367       R -> G (in CSID; dbSNP:rs143388292).
FT                                {ECO:0000269|PubMed:16329100}.
FT                                /FTId=VAR_025377.
FT   VARIANT    1523   1523       M -> I (in dbSNP:rs4855271).
FT                                {ECO:0000269|PubMed:1353958,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:16329100}.
FT                                /FTId=VAR_025378.
FT   VARIANT    1745   1745       F -> C (in CSID; dbSNP:rs79717168).
FT                                {ECO:0000269|PubMed:16329100}.
FT                                /FTId=VAR_025379.
FT   VARIANT    1802   1802       T -> S (in dbSNP:rs9917722).
FT                                /FTId=VAR_034522.
FT   CONFLICT    300    300       N -> D (in Ref. 3; AAI16453).
FT                                {ECO:0000305}.
FT   CONFLICT    460    460       S -> I (in Ref. 3; AAI15035).
FT                                {ECO:0000305}.
FT   CONFLICT    475    475       P -> S (in Ref. 3; AAI15035).
FT                                {ECO:0000305}.
FT   CONFLICT    548    548       A -> V (in Ref. 3; AAI16453).
FT                                {ECO:0000305}.
FT   CONFLICT    584    584       F -> L (in Ref. 3; AAI15035).
FT                                {ECO:0000305}.
FT   CONFLICT    588    588       R -> C (in Ref. 3; AAI15035).
FT                                {ECO:0000305}.
FT   CONFLICT    633    633       D -> A (in Ref. 3; AAI15035).
FT                                {ECO:0000305}.
FT   CONFLICT    687    687       Q -> R (in Ref. 3; AAI16453).
FT                                {ECO:0000305}.
FT   CONFLICT    884    884       T -> A (in Ref. 3; AAI15035).
FT                                {ECO:0000305}.
FT   CONFLICT   1016   1016       S -> E (in Ref. 5; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT   1022   1022       V -> T (in Ref. 5; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT   1155   1155       A -> V (in Ref. 3; AAI15035).
FT                                {ECO:0000305}.
FT   CONFLICT   1203   1203       E -> Q (in Ref. 1; CAA45140).
FT                                {ECO:0000305}.
FT   CONFLICT   1782   1782       V -> I (in Ref. 3; AAI15035).
FT                                {ECO:0000305}.
FT   CONFLICT   1825   1825       N -> S (in Ref. 3; AAI16453).
FT                                {ECO:0000305}.
FT   STRAND       65     68       {ECO:0000244|PDB:3LPP}.
FT   HELIX        71     73       {ECO:0000244|PDB:3LPP}.
FT   STRAND       75     77       {ECO:0000244|PDB:3LPO}.
FT   HELIX        85     91       {ECO:0000244|PDB:3LPP}.
FT   STRAND       99    103       {ECO:0000244|PDB:3LPP}.
FT   STRAND      105    107       {ECO:0000244|PDB:3LPP}.
FT   STRAND      114    121       {ECO:0000244|PDB:3LPP}.
FT   STRAND      123    132       {ECO:0000244|PDB:3LPP}.
FT   STRAND      138    140       {ECO:0000244|PDB:3LPP}.
FT   STRAND      144    154       {ECO:0000244|PDB:3LPP}.
FT   STRAND      157    163       {ECO:0000244|PDB:3LPP}.
FT   STRAND      175    177       {ECO:0000244|PDB:3LPP}.
FT   STRAND      189    195       {ECO:0000244|PDB:3LPP}.
FT   TURN        196    199       {ECO:0000244|PDB:3LPP}.
FT   STRAND      200    205       {ECO:0000244|PDB:3LPP}.
FT   TURN        206    209       {ECO:0000244|PDB:3LPP}.
FT   STRAND      210    214       {ECO:0000244|PDB:3LPP}.
FT   HELIX       215    217       {ECO:0000244|PDB:3LPP}.
FT   STRAND      221    223       {ECO:0000244|PDB:3LPP}.
FT   STRAND      226    232       {ECO:0000244|PDB:3LPP}.
FT   STRAND      234    236       {ECO:0000244|PDB:3LPP}.
FT   STRAND      238    244       {ECO:0000244|PDB:3LPP}.
FT   STRAND      247    250       {ECO:0000244|PDB:3LPP}.
FT   STRAND      254    261       {ECO:0000244|PDB:3LPP}.
FT   STRAND      278    284       {ECO:0000244|PDB:3LPP}.
FT   STRAND      291    296       {ECO:0000244|PDB:3LPP}.
FT   STRAND      302    307       {ECO:0000244|PDB:3LPP}.
FT   TURN        308    310       {ECO:0000244|PDB:3LPP}.
FT   STRAND      311    319       {ECO:0000244|PDB:3LPP}.
FT   STRAND      321    330       {ECO:0000244|PDB:3LPP}.
FT   HELIX       331    342       {ECO:0000244|PDB:3LPP}.
FT   HELIX       350    353       {ECO:0000244|PDB:3LPP}.
FT   HELIX       365    377       {ECO:0000244|PDB:3LPP}.
FT   STRAND      384    387       {ECO:0000244|PDB:3LPP}.
FT   HELIX       389    391       {ECO:0000244|PDB:3LPP}.
FT   HELIX       393    395       {ECO:0000244|PDB:3LPO}.
FT   TURN        402    407       {ECO:0000244|PDB:3LPP}.
FT   HELIX       408    417       {ECO:0000244|PDB:3LPP}.
FT   STRAND      421    426       {ECO:0000244|PDB:3LPP}.
FT   HELIX       442    450       {ECO:0000244|PDB:3LPP}.
FT   STRAND      459    462       {ECO:0000244|PDB:3LPP}.
FT   STRAND      465    467       {ECO:0000244|PDB:3LPP}.
FT   STRAND      470    473       {ECO:0000244|PDB:3LPP}.
FT   HELIX       480    496       {ECO:0000244|PDB:3LPP}.
FT   STRAND      500    504       {ECO:0000244|PDB:3LPP}.
FT   TURN        507    509       {ECO:0000244|PDB:3LPP}.
FT   STRAND      512    515       {ECO:0000244|PDB:3LPP}.
FT   TURN        524    526       {ECO:0000244|PDB:3LPP}.
FT   HELIX       535    537       {ECO:0000244|PDB:3LPP}.
FT   TURN        539    542       {ECO:0000244|PDB:3LPP}.
FT   HELIX       555    558       {ECO:0000244|PDB:3LPP}.
FT   HELIX       559    561       {ECO:0000244|PDB:3LPP}.
FT   HELIX       562    577       {ECO:0000244|PDB:3LPP}.
FT   STRAND      585    588       {ECO:0000244|PDB:3LPP}.
FT   HELIX       594    596       {ECO:0000244|PDB:3LPP}.
FT   STRAND      599    601       {ECO:0000244|PDB:3LPP}.
FT   STRAND      606    608       {ECO:0000244|PDB:3LPP}.
FT   HELIX       609    624       {ECO:0000244|PDB:3LPP}.
FT   STRAND      629    631       {ECO:0000244|PDB:3LPP}.
FT   STRAND      637    639       {ECO:0000244|PDB:3LPP}.
FT   HELIX       643    653       {ECO:0000244|PDB:3LPP}.
FT   STRAND      656    658       {ECO:0000244|PDB:3LPP}.
FT   HELIX       672    675       {ECO:0000244|PDB:3LPP}.
FT   HELIX       680    694       {ECO:0000244|PDB:3LPP}.
FT   HELIX       696    709       {ECO:0000244|PDB:3LPP}.
FT   STRAND      713    715       {ECO:0000244|PDB:3LPP}.
FT   HELIX       718    721       {ECO:0000244|PDB:3LPP}.
FT   HELIX       725    729       {ECO:0000244|PDB:3LPP}.
FT   STRAND      732    736       {ECO:0000244|PDB:3LPP}.
FT   TURN        737    739       {ECO:0000244|PDB:3LPP}.
FT   STRAND      740    743       {ECO:0000244|PDB:3LPP}.
FT   STRAND      751    757       {ECO:0000244|PDB:3LPP}.
FT   STRAND      762    764       {ECO:0000244|PDB:3LPP}.
FT   TURN        765    767       {ECO:0000244|PDB:3LPP}.
FT   STRAND      775    781       {ECO:0000244|PDB:3LPP}.
FT   STRAND      788    792       {ECO:0000244|PDB:3LPP}.
FT   STRAND      795    800       {ECO:0000244|PDB:3LPP}.
FT   HELIX       806    809       {ECO:0000244|PDB:3LPP}.
FT   STRAND      814    819       {ECO:0000244|PDB:3LPP}.
FT   STRAND      824    832       {ECO:0000244|PDB:3LPP}.
FT   STRAND      835    837       {ECO:0000244|PDB:3LPP}.
FT   HELIX       840    843       {ECO:0000244|PDB:3LPP}.
FT   STRAND      846    854       {ECO:0000244|PDB:3LPP}.
FT   STRAND      857    865       {ECO:0000244|PDB:3LPP}.
FT   HELIX       868    872       {ECO:0000244|PDB:3LPP}.
FT   STRAND      874    882       {ECO:0000244|PDB:3LPP}.
FT   STRAND      890    894       {ECO:0000244|PDB:3LPP}.
FT   STRAND      900    902       {ECO:0000244|PDB:3LPP}.
FT   STRAND      905    908       {ECO:0000244|PDB:3LPP}.
FT   TURN        909    912       {ECO:0000244|PDB:3LPP}.
FT   STRAND      913    916       {ECO:0000244|PDB:3LPP}.
FT   STRAND      927    930       {ECO:0000244|PDB:3LPP}.
SQ   SEQUENCE   1827 AA;  209453 MW;  DCB93F068AEEF83E CRC64;
     MARKKFSGLE ISLIVLFVIV TIIAIALIVV LATKTPAVDE ISDSTSTPAT TRVTTNPSDS
     GKCPNVLNDP VNVRINCIPE QFPTEGICAQ RGCCWRPWND SLIPWCFFVD NHGYNVQDMT
     TTSIGVEAKL NRIPSPTLFG NDINSVLFTT QNQTPNRFRF KITDPNNRRY EVPHQYVKEF
     TGPTVSDTLY DVKVAQNPFS IQVIRKSNGK TLFDTSIGPL VYSDQYLQIS TRLPSDYIYG
     IGEQVHKRFR HDLSWKTWPI FTRDQLPGDN NNNLYGHQTF FMCIEDTSGK SFGVFLMNSN
     AMEIFIQPTP IVTYRVTGGI LDFYILLGDT PEQVVQQYQQ LVGLPAMPAY WNLGFQLSRW
     NYKSLDVVKE VVRRNREAGI PFDTQVTDID YMEDKKDFTY DQVAFNGLPQ FVQDLHDHGQ
     KYVIILDPAI SIGRRANGTT YATYERGNTQ HVWINESDGS TPIIGEVWPG LTVYPDFTNP
     NCIDWWANEC SIFHQEVQYD GLWIDMNEVS SFIQGSTKGC NVNKLNYPPF TPDILDKLMY
     SKTICMDAVQ NWGKQYDVHS LYGYSMAIAT EQAVQKVFPN KRSFILTRST FAGSGRHAAH
     WLGDNTASWE QMEWSITGML EFSLFGIPLV GADICGFVAE TTEELCRRWM QLGAFYPFSR
     NHNSDGYEHQ DPAFFGQNSL LVKSSRQYLT IRYTLLPFLY TLFYKAHVFG ETVARPVLHE
     FYEDTNSWIE DTEFLWGPAL LITPVLKQGA DTVSAYIPDA IWYDYESGAK RPWRKQRVDM
     YLPADKIGLH LRGGYIIPIQ EPDVTTTASR KNPLGLIVAL GENNTAKGDF FWDDGETKDT
     IQNGNYILYT FSVSNNTLDI VCTHSSYQEG TTLAFQTVKI LGLTDSVTEV RVAENNQPMN
     AHSNFTYDAS NQVLLIADLK LNLGRNFSVQ WNQIFSENER FNCYPDADLA TEQKCTQRGC
     VWRTGSSLSK APECYFPRQD NSYSVNSARY SSMGITADLQ LNTANARIKL PSDPISTLRV
     EVKYHKNDML QFKIYDPQKK RYEVPVPLNI PTTPISTYED RLYDVEIKEN PFGIQIRRRS
     SGRVIWDSWL PGFAFNDQFI QISTRLPSEY IYGFGEVEHT AFKRDLNWNT WGMFTRDQPP
     GYKLNSYGFH PYYMALEEEG NAHGVFLLNS NAMDVTFQPT PALTYRTVGG ILDFYMFLGP
     TPEVATKQYH EVIGHPVMPA YWALGFQLCR YGYANTSEVR ELYDAMVAAN IPYDVQYTDI
     DYMERQLDFT IGEAFQDLPQ FVDKIRGEGM RYIIILDPAI SGNETKTYPA FERGQQNDVF
     VKWPNTNDIC WAKVWPDLPN ITIDKTLTED EAVNASRAHV AFPDFFRTST AEWWAREIVD
     FYNEKMKFDG LWIDMNEPSS FVNGTTTNQC RNDELNYPPY FPELTKRTDG LHFRTICMEA
     EQILSDGTSV LHYDVHNLYG WSQMKPTHDA LQKTTGKRGI VISRSTYPTS GRWGGHWLGD
     NYARWDNMDK SIIGMMEFSL FGMSYTGADI CGFFNNSEYH LCTRWMQLGA FYPYSRNHNI
     ANTRRQDPAS WNETFAEMSR NILNIRYTLL PYFYTQMHEI HANGGTVIRP LLHEFFDEKP
     TWDIFKQFLW GPAFMVTPVL EPYVQTVNAY VPNARWFDYH TGKDIGVRGQ FQTFNASYDT
     INLHVRGGHI LPCQEPAQNT FYSRQKHMKL IVAADDNQMA QGSLFWDDGE SIDTYERDLY
     LSVQFNLNQT TLTSTILKRG YINKSETRLG SLHVWGKGTT PVNAVTLTYN GNKNSLPFNE
     DTTNMILRID LTTHNVTLEE PIEINWS
//
